» Articles » PMID: 39804917

Comparison of a Non-invasive Point-of-care Measurement of Anemia to Conventionally Used HemoCue Devices in Gambella Refugee Camp, Ethiopia, 2022

Overview
Journal PLoS One
Date 2025 Jan 13
PMID 39804917
Authors
Affiliations
Soon will be listed here.
Abstract

Annual surveys of refugees in Gambella, Ethiopia suggest that anemia is a persistent public health problem among non-pregnant women of reproductive age (NP-WRA, 15-49 years). Measurement of anemia in most refugee camp settings is conducted using an invasive HemoCue 301. We assessed the accuracy and precision of a non-invasive, pulse CO-oximeter in measuring anemia among NP-WRA in four Gambella refugee camps. We conducted a population-representative household survey between November 7 and December 4, 2022. Hemoglobin (Hb) concentration was measured by HemoCue 301, using capillary blood, and Rad-67, a novel non-invasive device. We collected four measurements per participant: two per device. We calculated Rad-67 bias and precision of Hb measurements and sensitivity and specificity of detecting anemia. Of the 812 NP-WRAs selected, 807 (99%) participated in the study. Anemia was detected in 39% of NP-WRA as classified by the Rad-67 compared with 47% of NP-WRA as classified by the HemoCue 301. Average bias of Rad-67 measurements was 1.1 ± 1.0 SD g/dL, using HemoCue 301 as a comparator. Absolute mean difference between the first and second measurements was 0.9 g/dL (95% CI 0.8, 0.9) using the Rad-67, compared with 0.6 g/dL (95% CI 0.5, 0.6) using the HemoCue 301. The Rad-67 had 49% sensitivity and 70% specificity for detecting anemia, compared with the HemoCue 301. The Rad-67 can be a useful tool for anemia screening; however, lower accuracy and precision, and poor sensitivity suggest it cannot immediately replace the HemoCue 301 in the study area.

References
1.
Garcia-Casal M, Dary O, Jefferds M, Pasricha S . Diagnosing anemia: Challenges selecting methods, addressing underlying causes, and implementing actions at the public health level. Ann N Y Acad Sci. 2023; 1524(1):37-50. PMC: 10880862. DOI: 10.1111/nyas.14996. View

1.
Cervantes S, Stout P, Prudhomme J, Engel S, Bruton M, Cervantes M . High content live cell imaging for the discovery of new antimalarial marine natural products. BMC Infect Dis. 2012; 12:1. PMC: 3268092. DOI: 10.1186/1471-2334-12-1. View

2.
Arai Y, Shoji H, Awata K, Inage E, Ikuse T, Shimizu T . Evaluation of the use of non-invasive hemoglobin measurement in early childhood. Pediatr Res. 2022; 93(4):1036-1040. DOI: 10.1038/s41390-022-02204-7. View

3.
Shamah Levy T, Mendez-Gomez-Humaran I, Morales Ruan M, Martinez Tapia B, Villalpando Hernandez S, Hernandez Avila M . Validation of Masimo Pronto 7 and HemoCue 201 for hemoglobin determination in children from 1 to 5 years of age. PLoS One. 2017; 12(2):e0170990. PMC: 5295714. DOI: 10.1371/journal.pone.0170990. View

4.
Skelton V, Wijayasinghe N, Sharafudeen S, Sange A, Parry N, Junghans C . Evaluation of point-of-care haemoglobin measuring devices: a comparison of Radical-7™ pulse co-oximetry, HemoCue(®) and laboratory haemoglobin measurements in obstetric patients*. Anaesthesia. 2012; 68(1):40-5. DOI: 10.1111/anae.12039. View